Lilly Adds Warning to Strattera Label (Reuters) Reuters - Eli Lilly and Co  said Friday\it added a warning to the label of its attention\deficit/hyperactivity disorder medicine, advising patients with\jaundice or a liver injury to stop taking the treatment.